Prestige Consumer Healthcare
PBH
64,62 €
Prix de l'action
-2.16%
Changement (1 jour)
-0.77%
Changement (1 an)
Catégories
Prestige Consumer Healthcare (PBH) - Dette totale
Dette totale au bilan au Mars 2025 : 0.90 Milliard d'euros
Selon les derniers rapports financiers de Prestige Consumer Healthcare, la dette totale de l'entreprise est de 0.90 Milliard d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.
Prestige Consumer Healthcare - Dette totale au bilan (de 2004 à 2025)
Dette totale par année
| Année | Dette totale | Changement |
|---|---|---|
| 2024-03-31 | €1.05 Md | -16.09% |
| 2023-03-31 | €1.25 Md | -7.49% |
| 2022-03-31 | €1.36 Md | 5.35% |
| 2021-03-31 | €1.29 Md | -19.4% |
| 2020-03-31 | €1.60 Md | -0.02% |
| 2019-03-31 | €1.60 Md | -0.98% |
| 2018-03-31 | €1.61 Md | -21.09% |
| 2017-03-31 | €2.05 Md | 43.6% |
| 2016-03-31 | €1.42 Md | -1.77% |
| 2015-03-31 | €1.45 Md | 114.34% |
| 2014-03-31 | €0.67 Md | -10.53% |
| 2013-03-31 | €0.75 Md | -10.01% |
| 2012-03-31 | €0.84 Md | 144.97% |
| 2011-03-31 | €0.34 Md | 44.13% |
| 2010-03-31 | €0.23 Md | -16.49% |
| 2009-03-31 | €0.28 Md | 9.77% |
| 2008-03-31 | €0.26 Md | -25.06% |
| 2007-03-31 | €0.34 Md | -16.53% |
| 2006-03-31 | €0.41 Md | 8.45% |
| 2005-03-31 | €0.38 Md | 219.1% |
| 2004-03-31 | €0.12 Md |
Dette totale pour des entreprises similaires ou concurrentes
| Entreprise | Dette totale/th> | Dette totale différencediff. | Pays |
|---|---|---|---|
 GlaxoSmithKline GSK | €20.61 Md | 2,180.66% | 🇬🇧 UK |
 Pfizer PFE | €53.05 Md | 5,769.38% | 🇺🇸 USA |
 Rite Aid
RAD | €5.69 Md | 530.24% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €45.22 Md | 4,903.78% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | €1.68 M | -99.81% | 🇮🇱 Israel |
 Novartis NVS | €27.06 Md | 2,894.49% | 🇨🇭 Switzerland |
 Procter & Gamble PG | €29.55 Md | 3,169.43% | 🇺🇸 USA |
 CVS Health CVS | €70.29 Md | 7,677.16% | 🇺🇸 USA |
 Clorox CLX | €2.54 Md | 181.92% | 🇺🇸 USA |
 Abbott Laboratories ABT | €11.46 Md | 1,168.09% | 🇺🇸 USA |